Predictive Oncology Inc. A Popular AI Penny Stock Under 5
POAI Stock | USD 0.81 0.03 3.85% |
Under 67 percent of all Predictive Oncology's traders are curious in acquiring. The analysis of overall sentiment of trading Predictive Oncology stock suggests that a large number of investors are confidant at this time. Predictive Oncology's investing sentiment shows overall attitude of investors towards Predictive Oncology.
Predictive |
We recently compiled a list of the 7 Most Popular AI Penny Stocks Under 5. In this article, we are going to take a look at where Predictive Oncology Inc. stands against the other popular AI penny stocks under 5. An Analysis of AI Breakthroughs Artificial intelligence has become increasingly important for businesses and industries
Read at finance.yahoo.com
Predictive Oncology Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Predictive Oncology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Predictive Oncology Fundamental Analysis
We analyze Predictive Oncology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Predictive Oncology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Predictive Oncology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Predictive Oncology is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Predictive Oncology Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Predictive Oncology stock to make a market-neutral strategy. Peer analysis of Predictive Oncology could also be used in its relative valuation, which is a method of valuing Predictive Oncology by comparing valuation metrics with similar companies.
Peers
Predictive Oncology Related Equities
BNGO | Bionano Genomics | 8.33 | ||||
STXS | Stereotaxis | 7.17 | ||||
LUCY | Innovative Eyewear | 2.46 | ||||
DXR | Daxor | 1.69 | ||||
ISRG | Intuitive Surgical | 0.64 | ||||
PDEX | Pro Dex | 0.02 | ||||
NYXH | Nyxoah | 1.55 | ||||
MBOT | Microbot Medical | 2.02 | ||||
MLSS | Milestone Scientific | 2.94 | ||||
GCTK | GlucoTrack | 4.00 | ||||
NXGL | Nexgel | 4.22 | ||||
STSS | Sharps Technology | 5.29 | ||||
ZJYL | JIN MEDICAL | 7.14 |
Complementary Tools for Predictive Stock analysis
When running Predictive Oncology's price analysis, check to measure Predictive Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Predictive Oncology is operating at the current time. Most of Predictive Oncology's value examination focuses on studying past and present price action to predict the probability of Predictive Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Predictive Oncology's price. Additionally, you may evaluate how the addition of Predictive Oncology to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |